2018 Q4 Form 10-K Financial Statement

#000137367020000005 Filed on March 06, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q2 2017 Q4
Revenue $185.1M $157.3M $137.4M
YoY Change 34.71% 48.76% 14.71%
Cost Of Revenue $128.6M $116.2M $110.8M
YoY Change 16.06% 41.76% 22.3%
Gross Profit $36.99M $41.07M $29.00M
YoY Change 27.56% 78.33% -0.7%
Gross Profit Margin 19.98% 26.11% 21.1%
Selling, General & Admin $39.90M $20.02M $10.30M
YoY Change 287.38% 380.39% -1.9%
% of Gross Profit 107.87% 48.74% 35.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.140M $640.0K $90.00K
YoY Change 1166.67% 700.0% 0.0%
% of Gross Profit 3.08% 1.56% 0.31%
Operating Expenses $41.60M $20.02M $10.30M
YoY Change 303.88% 380.39% -0.96%
Operating Profit -$4.612M $21.05M $18.70M
YoY Change -124.67% 56.8% -0.55%
Interest Expense $700.0K $2.300M $1.800M
YoY Change -61.11%
% of Operating Profit 10.92% 9.63%
Other Income/Expense, Net -$200.0K $898.0K $100.0K
YoY Change -300.0% 132.64% -75.0%
Pretax Income $20.70M $24.23M $21.00M
YoY Change -1.43% 75.41% 9.95%
Income Tax $3.800M $5.235M $6.400M
% Of Pretax Income 18.36% 21.61% 30.48%
Net Earnings $13.35M $14.87M -$8.195M
YoY Change -262.95% 93.38% -206.76%
Net Earnings / Revenue 7.21% 9.45% -5.96%
Basic Earnings Per Share $0.26 $0.29 -$0.16
Diluted Earnings Per Share $0.26 $0.29 -$0.16
COMMON SHARES
Basic Shares Outstanding 50.72M shares 50.66M shares 50.58M shares
Diluted Shares Outstanding 50.78M shares

Balance Sheet

Concept 2018 Q4 2018 Q2 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.30M $37.10M $36.70M
YoY Change 4.36% 35.9% 4.26%
Cash & Equivalents $41.76M $41.20M $40.29M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $669.0M $581.4M $496.1M
Prepaid Expenses
Receivables $4.800M $6.200M $1.600M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $712.1M $624.7M $534.4M
YoY Change 33.25% 34.55% 19.31%
LONG-TERM ASSETS
Property, Plant & Equipment $4.690M $3.454M $804.0K
YoY Change 483.33% 379.72% -9.87%
Goodwill $680.0K $680.0K $0.00
YoY Change
Intangibles $856.0K $275.0K $0.00
YoY Change
Long-Term Investments $20.27M $19.49M $16.88M
YoY Change 20.09%
Other Assets $19.90M $27.00M $34.80M
YoY Change -42.82% -58.46% -51.67%
Total Long-Term Assets $71.93M $80.35M $76.60M
YoY Change -6.11% -10.75% -17.71%
TOTAL ASSETS
Total Short-Term Assets $712.1M $624.7M $534.4M
Total Long-Term Assets $71.93M $80.35M $76.60M
Total Assets $784.0M $705.0M $611.0M
YoY Change 28.32% 27.19% 12.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.10M $19.50M $22.40M
YoY Change 16.52% 19.63% 48.34%
Accrued Expenses $29.20M $21.10M $18.50M
YoY Change 57.84% 46.53% 29.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $87.30M $74.60M $62.30M
YoY Change 40.13% 49.2% 43.22%
LONG-TERM LIABILITIES
Long-Term Debt $208.9M $174.3M $115.7M
YoY Change 80.55% 107.01% 34.69%
Other Long-Term Liabilities $2.200M $600.0K $0.00
YoY Change -93.02% -100.0%
Total Long-Term Liabilities $211.1M $174.9M $115.7M
YoY Change 82.45% 88.47% 20.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $87.30M $74.60M $62.30M
Total Long-Term Liabilities $211.1M $174.9M $115.7M
Total Liabilities $289.9M $242.8M $178.0M
YoY Change 62.88% 69.97% 27.57%
SHAREHOLDERS EQUITY
Retained Earnings $177.5M $152.0M $125.9M
YoY Change 41.0% 21.76% 13.49%
Common Stock $291.8M $291.3M $290.4M
YoY Change 0.47% 5.9% 6.14%
Preferred Stock
YoY Change
Treasury Stock (at cost) $981.0K $0.00 $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $468.4M $443.3M $416.3M
YoY Change
Total Liabilities & Shareholders Equity $784.0M $705.0M $611.0M
YoY Change 28.32% 27.19% 12.94%

Cashflow Statement

Concept 2018 Q4 2018 Q2 2017 Q4
OPERATING ACTIVITIES
Net Income $13.35M $14.87M -$8.195M
YoY Change -262.95% 93.38% -206.76%
Depreciation, Depletion And Amortization $1.140M $640.0K $90.00K
YoY Change 1166.67% 700.0% 0.0%
Cash From Operating Activities -$1.150M $7.920M $5.160M
YoY Change -122.29% -161.49% -556.64%
INVESTING ACTIVITIES
Capital Expenditures -$1.440M -$580.0K -$120.0K
YoY Change 1100.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$26.10M -$50.00K
YoY Change -100.0%
Cash From Investing Activities -$1.450M -$26.68M -$170.0K
YoY Change 752.94% 41.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -660.0K 21.11M 10.21M
YoY Change -106.46% 209.53% -264.41%
NET CHANGE
Cash From Operating Activities -1.150M 7.920M 5.160M
Cash From Investing Activities -1.450M -26.68M -170.0K
Cash From Financing Activities -660.0K 21.11M 10.21M
Net Change In Cash -3.260M 2.350M 15.20M
YoY Change -121.45% -138.78% -303.75%
FREE CASH FLOW
Cash From Operating Activities -$1.150M $7.920M $5.160M
Capital Expenditures -$1.440M -$580.0K -$120.0K
Free Cash Flow $290.0K $8.500M $5.280M
YoY Change -94.51% -165.99% -622.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001373670
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-33530
CY2019 dei Entity Registrant Name
EntityRegistrantName
Green Brick Partners, Inc.
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5952523
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
2805 Dallas Pkwy
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 400
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Plano
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75093
CY2019 dei City Area Code
CityAreaCode
(469)
CY2019 dei Local Phone Number
LocalPhoneNumber
573-6755
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2019 dei Trading Symbol
TradingSymbol
GRBK
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
198930713 USD
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50488010 shares
CY2018Q4 dei Entity Number Of Employees
EntityNumberOfEmployees
460 employee
CY2019Q4 us-gaap Cash
Cash
33269000 USD
CY2018Q4 us-gaap Cash
Cash
38315000 USD
CY2018Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
4842000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
4416000 USD
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
3440000 USD
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
4720000 USD
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
753567000 USD
CY2018Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
668961000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
30294000 USD
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
20269000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3462000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4309000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4690000 USD
CY2019Q4 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
14686000 USD
CY2018Q4 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
16793000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15262000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16499000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
707000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
856000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
680000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
680000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
10167000 USD
CY2018Q4 us-gaap Other Assets
OtherAssets
8681000 USD
CY2019Q4 us-gaap Assets
Assets
875539000 USD
CY2018Q4 us-gaap Assets
Assets
784026000 USD
CY2019Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
30044000 USD
CY2018Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
26091000 USD
CY2019Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
24656000 USD
CY2018Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
29201000 USD
CY2019Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
23954000 USD
CY2018Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
31978000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3564000 USD
CY2018Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
164642000 USD
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
200386000 USD
CY2019Q4 us-gaap Senior Notes
SeniorNotes
73406000 USD
CY2018Q4 us-gaap Senior Notes
SeniorNotes
0 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5267000 USD
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2207000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
325533000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
289863000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
13611000 USD
CY2018Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
8531000 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
509000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
507000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
98659000 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80702000 USD
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58442000 USD
CY2019Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3167000 USD
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
981000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
290799000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
291299000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
235027000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
177526000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
523168000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
468351000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
13227000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
17281000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
536395000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
485632000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
875539000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
784026000 USD
CY2019 us-gaap Revenues
Revenues
791660000 USD
CY2018 us-gaap Revenues
Revenues
623647000 USD
CY2017 us-gaap Revenues
Revenues
458250000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
622578000 USD
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
469445000 USD
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
339790000 USD
CY2019 us-gaap Gross Profit
GrossProfit
169082000 USD
CY2018 us-gaap Gross Profit
GrossProfit
154202000 USD
CY2017 us-gaap Gross Profit
GrossProfit
118460000 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4906000 USD
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1693000 USD
CY2017 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9809000 USD
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7259000 USD
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2746000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9003000 USD
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2605000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1473000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
84329000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81671000 USD
CY2017 us-gaap Results Of Operations Income Before Income Taxes
ResultsOfOperationsIncomeBeforeIncomeTaxes
64237000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20027000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17136000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39031000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
64302000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
64535000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
25206000 USD
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5646000 USD
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12912000 USD
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
10236000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
58656000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
51623000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
14970000 USD
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50530000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50652000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49597000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50636000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50751000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49683000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48955909 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
490000 USD
CY2016Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2016Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
273149000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
110933000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
384572000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
16913000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
401485000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
289000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
289000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
289000 USD
CY2017 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
229049 shares
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1926000 USD
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1926000 USD
CY2017 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
63057 shares
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
586000 USD
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
586000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
356000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
356000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
356000 USD
CY2017 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
1477000 shares
CY2017 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2017 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
14622000 USD
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
14622000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
416347000 USD
CY2017 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
438000 USD
CY2017 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
438000 USD
CY2017 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10896000 USD
CY2017 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10896000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
14970000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
14970000 USD
CY2017 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
10236000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
25206000 USD
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50598901 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
506000 USD
CY2017Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
289938000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
125903000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
16691000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
433038000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
288000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
288000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
288000 USD
CY2018 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
140211 shares
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1082000 USD
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1082000 USD
CY2018 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
39228 shares
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
412000 USD
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
412000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
404000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
404000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
404000 USD
CY2018Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
20000 shares
CY2018 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
136756 shares
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
981000 USD
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
981000 USD
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
981000 USD
CY2018 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5000 USD
CY2018 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5000 USD
CY2018 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10747000 USD
CY2018 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10747000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
51623000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
51623000 USD
CY2018 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
11332000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
507000 USD
CY2018 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
62955000 USD
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50719884 shares
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
236000 USD
CY2019 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
219181 shares
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
136756 shares
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
981000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
291299000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
177526000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
468351000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
17281000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
485632000 USD
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50719884 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
507000 USD
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
136756 shares
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
981000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
291299000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
177526000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
468351000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
17281000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
485632000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
236000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
236000 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1466000 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1466000 USD
CY2019 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
59116 shares
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
544000 USD
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
544000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
489000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
489000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
489000 USD
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
255183 shares
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2186000 USD
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2186000 USD
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2186000 USD
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3600000 USD
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3600000 USD
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10993000 USD
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10993000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
58656000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
58656000 USD
CY2019 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
2184000 USD
CY2019 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
60840000 USD
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50879949 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
523168000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
13227000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
509000 USD
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
391939 shares
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3167000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
290799000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
235027000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
536395000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
64302000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
64535000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
25206000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3079000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2943000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
325000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2191000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1774000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
2571000 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4906000 USD
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1693000 USD
CY2017 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1237000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14712000 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36299000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9809000 USD
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7259000 USD
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2746000 USD
CY2019 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5084000 USD
CY2018 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4623000 USD
CY2017 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
974000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-122000 USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3029000 USD
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-843000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
83970000 USD
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
129291000 USD
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
95452000 USD
CY2019 us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
-2107000 USD
CY2018 us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
-2119000 USD
CY2017 us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
3097000 USD
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1525000 USD
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2741000 USD
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1701000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3953000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-483000 USD
CY2017 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
7241000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4384000 USD
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9470000 USD
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4175000 USD
CY2019 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1332000 USD
CY2018 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 USD
CY2017 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 USD
CY2019 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-8024000 USD
CY2018 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
1458000 USD
CY2017 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
7359000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22063000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39476000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18003000 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
26861000 USD
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2019 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5300000 USD
CY2018 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
755000 USD
CY2017 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
286000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2569000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3211000 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
149000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7869000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30827000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-435000 USD
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
224000000 USD
CY2018 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
165000000 USD
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
88500000 USD
CY2019 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
75000000 USD
CY2018 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2017 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1974000 USD
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
870000 USD
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
809000 USD
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
260000000 USD
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
70000000 USD
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
56500000 USD
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10226000 USD
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1022000 USD
CY2019 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
514000 USD
CY2018 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
CY2017 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
544000 USD
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
412000 USD
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
586000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2186000 USD
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
981000 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3600000 USD
CY2018 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5000 USD
CY2017 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
438000 USD
CY2019 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
10993000 USD
CY2018 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
10747000 USD
CY2017 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
10896000 USD
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-527000 USD
CY2018 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2017 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25862000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71769000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19125000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4070000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1466000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
687000 USD
CY2018Q4 us-gaap Cash
Cash
38315000 USD
CY2017Q4 us-gaap Cash
Cash
36684000 USD
CY2016Q4 us-gaap Cash
Cash
35157000 USD
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
3440000 USD
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
3605000 USD
CY2016Q4 us-gaap Restricted Cash
RestrictedCash
4445000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41755000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40289000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39602000 USD
CY2019Q4 us-gaap Cash
Cash
33269000 USD
CY2018Q4 us-gaap Cash
Cash
38315000 USD
CY2017Q4 us-gaap Cash
Cash
36684000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
4416000 USD
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
3440000 USD
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
3605000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37685000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41755000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40289000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2017 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
14313000 USD
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
4611000 USD
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
2941000 USD
CY2019 grbk Noncash Or Part Noncash Equity Investment Noncash Financial Or Equity Instrument Consideration Equity Issued Value
NoncashOrPartNoncashEquityInvestmentNoncashFinancialOrEquityInstrumentConsiderationEquityIssuedValue
0 USD
CY2018 grbk Noncash Or Part Noncash Equity Investment Noncash Financial Or Equity Instrument Consideration Equity Issued Value
NoncashOrPartNoncashEquityInvestmentNoncashFinancialOrEquityInstrumentConsiderationEquityIssuedValue
0 USD
CY2017 grbk Noncash Or Part Noncash Equity Investment Noncash Financial Or Equity Instrument Consideration Equity Issued Value
NoncashOrPartNoncashEquityInvestmentNoncashFinancialOrEquityInstrumentConsiderationEquityIssuedValue
14622000 USD
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Use of Estimates</span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with GAAP requires management of the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes, including the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2019 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Reclassifications</span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation.</span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beginning in the first quarter of 2019, the Company reclassified its sales commission expenses from cost of residential units to selling, general and administrative expense in the consolidated statements of income in order to be more comparable with a majority of its peers. There was no impact on net income from the reclassification in any period.</span></div>
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Business Combination Reason For Business Combination
BusinessCombinationReasonForBusinessCombination
The acquisition allowed the Company to expand its operations into a new geographic market.
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Description
BusinessCombinationContingentConsiderationArrangementsDescription
Under the terms of the purchase agreement, the Company may be obligated to pay contingent consideration to our partner if certain annual performance targets are met over the three-year period following the Acquisition Date. The contingent consideration amounts are not contractually limited.
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
8399000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
45005000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
1462000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
850000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
290000 USD
CY2018Q2 us-gaap Goodwill
Goodwill
680000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
898000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
57584000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
300000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
5486000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
9073000 USD
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
14859000 USD
CY2018Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
6951000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
200000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
100000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
85000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
85000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
85000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
85000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
85000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
grbk Contingent Consideration Earned
ContingentConsiderationEarned
1800000 USD
us-gaap Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid
DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid
500000 USD
CY2019Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
265300000 USD
CY2019Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
279800000 USD
CY2019 grbk Contingent Consideration Earned
ContingentConsiderationEarned
5300000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
0 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2018Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
8531000 USD
CY2019 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
3462000 USD
CY2019 us-gaap Temporary Equity Interest In Subsidiary Earnings
TemporaryEquityInterestInSubsidiaryEarnings
527000 USD
CY2019 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2145000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
13611000 USD
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3600000 USD
CY2019Q4 grbk Equity Method Investment Board Seats
EquityMethodInvestmentBoardSeats
3
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2018Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
262900000 USD
CY2018Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
234000000.0 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
2000000.0 USD
CY2019 us-gaap Guarantee Obligations Term
GuaranteeObligationsTerm
35 months
CY2019Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
2000000.0 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Variable Interest Entity Nonconsolidated Carrying Amount Assets
VariableInterestEntityNonconsolidatedCarryingAmountAssets
23700000 USD
CY2019Q4 us-gaap Variable Interest Entity Nonconsolidated Carrying Amount Liabilities
VariableInterestEntityNonconsolidatedCarryingAmountLiabilities
13100000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
7300000 USD
CY2019Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
2000000.0 USD
CY2019Q4 grbk Finished Homesand Homesunder Construction
FinishedHomesandHomesunderConstruction
314966000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2018Q4 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
389000 USD
CY2016Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
9417000 USD
CY2019 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
12140000 USD
CY2018Q4 grbk Finished Homesand Homesunder Construction
FinishedHomesandHomesunderConstruction
268763000 USD
CY2019Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
437553000 USD
CY2018Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
399809000 USD
CY2019Q4 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
1048000 USD
CY2019Q4 us-gaap Inventory Real Estate
InventoryRealEstate
753567000 USD
CY2018Q4 us-gaap Inventory Real Estate
InventoryRealEstate
668961000 USD
CY2018Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
14780000 USD
CY2017Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
10474000 USD
CY2018 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
9003000 USD
CY2017 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
4456000 USD
CY2019 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
8324000 USD
CY2018 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
4697000 USD
CY2017 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
3399000 USD
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
18596000 USD
CY2018Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
14780000 USD
CY2017Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
10474000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 grbk Inventorywithpotentialindicatorsofimpairment
Inventorywithpotentialindicatorsofimpairment
11200000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
100000 USD
CY2018 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
100000 USD
CY2017 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
100000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 grbk Equity Method Investment Summarized Financial Information Cash
EquityMethodInvestmentSummarizedFinancialInformationCash
11699000 USD
CY2018Q4 grbk Equity Method Investment Summarized Financial Information Cash
EquityMethodInvestmentSummarizedFinancialInformationCash
14584000 USD
CY2019Q4 grbk Equity Method Investment Summarized Financial Information Accounts Receivable
EquityMethodInvestmentSummarizedFinancialInformationAccountsReceivable
3252000 USD
CY2018Q4 grbk Equity Method Investment Summarized Financial Information Accounts Receivable
EquityMethodInvestmentSummarizedFinancialInformationAccountsReceivable
1259000 USD
CY2019Q4 grbk Equity Method Investments Summarized Financial Information Bonds Receivable
EquityMethodInvestmentsSummarizedFinancialInformationBondsReceivable
5864000 USD
CY2018Q4 grbk Equity Method Investments Summarized Financial Information Bonds Receivable
EquityMethodInvestmentsSummarizedFinancialInformationBondsReceivable
5864000 USD
CY2019Q4 grbk Equity Method Investment Summarized Financial Information Loans Held For Sale
EquityMethodInvestmentSummarizedFinancialInformationLoansHeldForSale
23143000 USD
CY2018Q4 grbk Equity Method Investment Summarized Financial Information Loans Held For Sale
EquityMethodInvestmentSummarizedFinancialInformationLoansHeldForSale
3083000 USD
CY2019Q4 grbk Equity Method Investment Summarized Financial Information Inventory
EquityMethodInvestmentSummarizedFinancialInformationInventory
73704000 USD
CY2018Q4 grbk Equity Method Investment Summarized Financial Information Inventory
EquityMethodInvestmentSummarizedFinancialInformationInventory
44375000 USD
CY2019Q4 grbk Equity Method Investment Summarized Financial Information Other Assets
EquityMethodInvestmentSummarizedFinancialInformationOtherAssets
4012000 USD
CY2018Q4 grbk Equity Method Investment Summarized Financial Information Other Assets
EquityMethodInvestmentSummarizedFinancialInformationOtherAssets
3132000 USD
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
121674000 USD
CY2018Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
72297000 USD
CY2019Q4 grbk Equity Method Investment Summarized Financial Information Accounts Payable
EquityMethodInvestmentSummarizedFinancialInformationAccountsPayable
1726000 USD
CY2018Q4 grbk Equity Method Investment Summarized Financial Information Accounts Payable
EquityMethodInvestmentSummarizedFinancialInformationAccountsPayable
2173000 USD
CY2019Q4 grbk Equity Method Investment Summarized Financial Information Accrued Expensesand Other Liabilities
EquityMethodInvestmentSummarizedFinancialInformationAccruedExpensesandOtherLiabilities
7784000 USD
CY2018Q4 grbk Equity Method Investment Summarized Financial Information Accrued Expensesand Other Liabilities
EquityMethodInvestmentSummarizedFinancialInformationAccruedExpensesandOtherLiabilities
5328000 USD
CY2019Q4 grbk Equity Method Investment Summarized Financial Information Notes Payable
EquityMethodInvestmentSummarizedFinancialInformationNotesPayable
58223000 USD
CY2018Q4 grbk Equity Method Investment Summarized Financial Information Notes Payable
EquityMethodInvestmentSummarizedFinancialInformationNotesPayable
31402000 USD
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
67733000 USD
CY2018Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
38903000 USD
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Minority Interest
EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest
25910000 USD
CY2018Q4 us-gaap Equity Method Investment Summarized Financial Information Minority Interest
EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest
15653000 USD
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Equity Or Capital
EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital
28031000 USD
CY2018Q4 us-gaap Equity Method Investment Summarized Financial Information Equity Or Capital
EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital
17741000 USD
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
53941000 USD
CY2018Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
33394000 USD
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
121674000 USD
CY2018Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
72297000 USD
CY2019 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
166368000 USD
CY2018 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
166102000 USD
CY2017 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
58958000 USD
CY2019 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
144097000 USD
CY2018 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
148222000 USD
CY2017 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
44969000 USD
CY2019 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
22271000 USD
CY2018 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
17880000 USD
CY2017 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
13989000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9809000 USD
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7259000 USD
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2746000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10550000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9362000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6241000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4672000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4309000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4690000 USD
CY2019 us-gaap Depreciation
Depreciation
2900000 USD
CY2018 us-gaap Depreciation
Depreciation
2700000 USD
CY2017 us-gaap Depreciation
Depreciation
300000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
17860000 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
148140000 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
12500000 USD
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
62500000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
241000000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1358000 USD
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1614000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
164642000 USD
CY2018Q4 us-gaap Line Of Credit
LineOfCredit
200386000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
66100000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q3 us-gaap Senior Notes
SeniorNotes
75000000.0 USD
CY2019Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0400
CY2019Q3 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
73300000 USD
CY2019Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
1500000 USD
CY2019Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
200000 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50879949 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50488010 shares
CY2018Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
20000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0 USD
CY2018Q4 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
136756 shares
CY2016Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1000000 shares
CY2017 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2018Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1000000.0 USD
CY2019Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
7862 shares
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
39320 shares
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300000 USD
CY2019Q3 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2019-08-05
CY2019Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
144584 shares
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1200000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
63417 shares
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
600000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
26800000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2350956 shares
CY2018Q4 dei Entity Number Of Employees
EntityNumberOfEmployees
460 employee
CY2017 grbk Sharebased Compensation Arrangementby Sharebased Payment Award Maximum Amounttobe Paidto Individual
SharebasedCompensationArrangementbySharebasedPaymentAwardMaximumAmounttobePaidtoIndividual
2000000.0 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1656703 shares
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
59116 shares
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
500000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
38000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
7.51
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
229000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.11
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
229000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
9.66
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
38000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.25
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
140000 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.45
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
144000 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
10.03
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
34000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.00
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
219000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.14
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
194000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
9.67
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
59000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.05
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
500000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.49
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
500000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.49
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M25D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1995000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
500000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.49
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M25D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1995000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
100000 shares
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.88
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
100000 shares
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.88
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0 shares
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
0 shares
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.88
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2200000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1800000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
2600000 USD
CY2019 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
500000 USD
CY2018 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
400000 USD
CY2017 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
600000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1900000 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1400000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
2200000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2017 us-gaap Interest Expense
InterestExpense
0 USD
CY2019 us-gaap Results Of Operations Income Before Income Taxes
ResultsOfOperationsIncomeBeforeIncomeTaxes
84329000 USD
CY2018 us-gaap Results Of Operations Income Before Income Taxes
ResultsOfOperationsIncomeBeforeIncomeTaxes
81671000 USD
CY2017 us-gaap Results Of Operations Income Before Income Taxes
ResultsOfOperationsIncomeBeforeIncomeTaxes
64237000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
21305000 USD
CY2018 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
21148000 USD
CY2019 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
50400000 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
30333000 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
18940000 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1160000 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
50433000 USD
CY2019 us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
Our contracts with homebuyers have a duration of less than one year. As such, the Company uses the practical expedient as allowed under ASC 606 and has not disclosed the transaction price allocated to remaining performance obligations as of the end of the reporting period.
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Revenues
Revenues
791660000 USD
CY2018 us-gaap Revenues
Revenues
623647000 USD
CY2017 us-gaap Revenues
Revenues
458250000 USD
CY2019 us-gaap Gross Profit
GrossProfit
169082000 USD
CY2018 us-gaap Gross Profit
GrossProfit
154202000 USD
CY2017 us-gaap Gross Profit
GrossProfit
118460000 USD
CY2019 us-gaap Interest Expense
InterestExpense
0 USD
CY2018 us-gaap Interest Expense
InterestExpense
0 USD
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
753567000 USD
CY2018Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
668961000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
680000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
680000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
15980000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-569000 USD
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
999000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2810000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2993000 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1733000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18790000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2424000 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2732000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
774000 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
15023000 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
36569000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
463000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-311000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-270000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1237000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14712000 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36299000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20027000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17136000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39031000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
17709000 USD
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
17151000 USD
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
22483000 USD
CY2019 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
1252000 USD
CY2018 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
2743000 USD
CY2017 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
3630000 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2706000 USD
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1940000 USD
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
931000 USD
CY2019 grbk Writeoffofstatenetoperatinglosses
Writeoffofstatenetoperatinglosses
1063000 USD
CY2018 grbk Writeoffofstatenetoperatinglosses
Writeoffofstatenetoperatinglosses
283000 USD
CY2017 grbk Writeoffofstatenetoperatinglosses
Writeoffofstatenetoperatinglosses
41000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1063000 USD
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-283000 USD
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-41000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 USD
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 USD
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
19017000 USD
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
864000 USD
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
788000 USD
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
230000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20027000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17136000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39031000 USD
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.608
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
19000000.0 USD
CY2019Q4 grbk Deferred Tax Assets Basisin Partnership
DeferredTaxAssetsBasisinPartnership
9212000 USD
CY2018Q4 grbk Deferred Tax Assets Basisin Partnership
DeferredTaxAssetsBasisinPartnership
10947000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
2206000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
2182000 USD
CY2019Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
2316000 USD
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1521000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
1444000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
385000 USD
CY2019Q4 grbk Deferred Tax Assets Operating Leases Liabilities
DeferredTaxAssetsOperatingLeasesLiabilities
832000 USD
CY2018Q4 grbk Deferred Tax Assets Operating Leases Liabilities
DeferredTaxAssetsOperatingLeasesLiabilities
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1063000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
432000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
576000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
408000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
347000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
191000 USD
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
175000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16609000 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17628000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1063000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
16609000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
16565000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
818000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
0 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
419000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
66000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
110000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1347000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
66000 USD
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
13700000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1063000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1346000 USD
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1063000 USD
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
283000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1063000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
14970000 USD
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50530000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50652000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49597000 shares
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
249000 USD
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
249000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
800000 USD
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000 USD
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
500000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
58656000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
51623000 USD
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50530000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50652000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49597000 shares
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
106000 shares
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
99000 shares
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
86000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50636000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50751000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49683000 shares
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14000 shares
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8000 shares
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Measurement Input
BusinessCombinationContingentConsiderationLiabilityMeasurementInput
0.165
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2207000 USD
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2207000 USD
CY2019 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
514000 USD
CY2019 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
514000 USD
CY2019 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1332000 USD
CY2019 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1332000 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4906000 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4906000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5267000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5267000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
9000000.0 USD
CY2018Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2200000 USD
CY2019Q4 us-gaap Special Assessment Bond
SpecialAssessmentBond
5400000 USD
CY2018Q4 us-gaap Special Assessment Bond
SpecialAssessmentBond
5300000 USD
CY2019 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
37000 USD
CY2018 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
163000 USD
CY2017 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
482000 USD
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1200000 USD
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1200000 USD
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
900000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0522
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1320000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1096000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
819000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1218000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
14000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4467000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
903000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3564000 USD
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000 USD
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31

Files In Submission

Name View Source Status
0001373670-20-000005-index-headers.html Edgar Link pending
0001373670-20-000005-index.html Edgar Link pending
0001373670-20-000005.txt Edgar Link pending
0001373670-20-000005-xbrl.zip Edgar Link pending
a201910-k.htm Edgar Link pending
a201910-k_htm.xml Edgar Link completed
exhibit102.htm Edgar Link pending
exhibit102001.jpg Edgar Link pending
exhibit102002.jpg Edgar Link pending
exhibit102003.jpg Edgar Link pending
exhibit102004.jpg Edgar Link pending
exhibit102005.jpg Edgar Link pending
exhibit102006.jpg Edgar Link pending
exhibit102007.jpg Edgar Link pending
exhibit102008.jpg Edgar Link pending
exhibit102009.jpg Edgar Link pending
exhibit102010.jpg Edgar Link pending
exhibit102011.jpg Edgar Link pending
exhibit102012.jpg Edgar Link pending
exhibit102013.jpg Edgar Link pending
exhibit102014.jpg Edgar Link pending
exhibit102015.jpg Edgar Link pending
exhibit102016.jpg Edgar Link pending
exhibit102017.jpg Edgar Link pending
exhibit102018.jpg Edgar Link pending
exhibit102019.jpg Edgar Link pending
exhibit102020.jpg Edgar Link pending
exhibit102021.jpg Edgar Link pending
exhibit102022.jpg Edgar Link pending
exhibit102023.jpg Edgar Link pending
exhibit102024.jpg Edgar Link pending
exhibit102025.jpg Edgar Link pending
exhibit102026.jpg Edgar Link pending
exhibit102027.jpg Edgar Link pending
exhibit102028.jpg Edgar Link pending
exhibit102029.jpg Edgar Link pending
exhibit102030.jpg Edgar Link pending
exhibit102031.jpg Edgar Link pending
exhibit102032.jpg Edgar Link pending
exhibit102033.jpg Edgar Link pending
exhibit102034.jpg Edgar Link pending
exhibit102035.jpg Edgar Link pending
exhibit102036.jpg Edgar Link pending
exhibit102037.jpg Edgar Link pending
exhibit102038.jpg Edgar Link pending
exhibit102039.jpg Edgar Link pending
exhibit102040.jpg Edgar Link pending
exhibit102041.jpg Edgar Link pending
exhibit102042.jpg Edgar Link pending
exhibit102043.jpg Edgar Link pending
exhibit102044.jpg Edgar Link pending
exhibit21listofsubsidi.htm Edgar Link pending
exhibit23consentofrsmu.htm Edgar Link pending
exhibit311certificatio.htm Edgar Link pending
exhibit312certificatio.htm Edgar Link pending
exhibit321certificatio.htm Edgar Link pending
exhibit322certificatio.htm Edgar Link pending
exhibit42.htm Edgar Link pending
exhibit42001.jpg Edgar Link pending
exhibit42002.jpg Edgar Link pending
exhibit42003.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
grbk-20191231.xsd Edgar Link pending
grbk-20191231_cal.xml Edgar Link unprocessable
grbk-20191231_def.xml Edgar Link unprocessable
grbk-20191231_lab.xml Edgar Link unprocessable
grbk-20191231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending